Bookmarks
Population Size
504
People
Years
2019
Associated BioSamples
Serum
DNA
...see more
Geographic coverage
UK and USA
Lead time
Variable
Summary
Documentation
Dataset type
Dataset population size
Associated media
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
|---|---|---|---|---|
Persons | Number of individuals enrolled into DELIVER-MS (UK and USA) providing biorepository samples | 504 | persons diagnosed with RRMS | 10 Sep 2025 |
Persons | Number of individuals enrolled into DELIVER-MS (UK) providing biorepository samples | 234 | persons diagnosed with RRMS | 09 Sep 2025 |
Persons | Number of individuals enrolled into DELIVER-MS (USA) providing biorepository samples | 270 | persons diagnosed with RRMS | 09 Sep 2025 |
Persons | Number of participants providing plasma samples | 232 | persons diagnosed with RRMS | 09 Sep 2025 |
Persons | Number of participants providing serum samples | 411 | persons diagnosed with RRMS | 09 Sep 2025 |
Persons | Number of participants providing DNA samples | 419 | persons diagnosed with RRMS | 09 Sep 2025 |
Persons | Number of participants providing PBMC samples | 448 | persons diagnosed with RRMS | 09 Sep 2025 |
Events | Number of plasma sample aliquots | 3554 | sample aliquot | 09 Sep 2025 |
Events | Number of serum sample aliquots | 5626 | sample aliquot | 09 Sep 2025 |
Events | Number of DNA sample aliquots | 456 | sample aliquot | 09 Sep 2025 |
Events | Number of PBMC sample aliquots | 2948 | sample aliquot | 09 Sep 2025 |
Events | Number of total sample aliquots provided to date | 12584 | sample aliquot | 09 Sep 2025 |
Persons | Number of participants initially commenced on Alemtuzumab | 8 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Cladribine | 34 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Dimethyl Fumurate | 67 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Diroximol Fumurate | 8 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Fingolimod | 18 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Glatiramer Acetate | 22 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on IFN Beta 1a | 6 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Natalizumab | 36 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Ocreluzimab | 178 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Ofatumumab | 53 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Ozanimod | 21 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Peg-IFN beta 1a | 12 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Ponesimod | 4 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Rituximab | 13 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Siponimod | 3 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Teriflunomide | 5 | people | 09 Sep 2025 |
Events | Number of participants initially commenced on Ublituximab | 1 | people | 09 Sep 2025 |
Persons | Number of participants initially commenced on Unknown DMT | 16 | people | 09 Sep 2025 |
Provenance
Purpose of dataset collection
Source of data extraction
Collection source setting
Patient pathway description
Image contrast
Biological sample availability
Structural Metadata
Details
Publishing frequency
Version
Modified
24/11/2025
Distribution release date
01/01/2027
Citation Requirements
Coverage
Start date
30/11/2019
Time lag
Geographic coverage
Minimum age range
Maximum age range
Follow-up
Accessibility
Language
Alignment with standardised data models
Controlled vocabulary
Format
Data Access Request
Dataset pipeline status
Access rights
Time to dataset access
Access request cost
Access method category
Access service description
Jurisdiction
Data use limitation
Data use requirements
Data Controller
Data Processor